Podcast series

The ECNP podcast series brings you conversations with some of the leading researchers in applied neuroscience, discussing their work, their career, their vision on the field, and why they do what they do. 


Podcast 5 — On what it was like to be an Early Career Scientist two decades ago, comorbidities in ADHD, being part of the ECNP Network ADHD across the lifespan and the impact of the pandemic *
Duration: 45 min

ecnp-stamp-podcast-blueMarch 2022 — Andreas Reif, Germany, past-chair of the Scientific Programme Committee (SPC), is in conversation with Early Career Advisory Panel (ECAP) past chair Nils Opel, Germany. Andreas Reif, who studies molecular underpinnings of neuropsychiatric disorders, talks about his life in science and how science has sped up since he started his career. In addition, he shares some advice on how to ensure a successful career start, elaborates on his participation in research networks and the impact of the Covid-19 pandemic on research and mental health.

Listen

Read more about Andreas Reif and interviewer Nils Opel.

*Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

Podcast 4On the value of scientific work, collaboration and communication, the younger generation and being a woman in science*
Duration: 30 min

ecnp-stamp-podcast-blueMarch 2022 — ECNP President Gitte Moos Knudsen, Denmark talks about neurobiology, her personal career history and future plans.
Additionally, she gives advice to early career researchers on creating a successful career without neglecting personal life. 

Listen

Read more about Gitte Moos Knudsen and interviewer Sofi Atshemyan.

*Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.


Podcast 3 Mechanisms behind emotional processing and drug response in the treatment of depression and anxiety*
Duration: 45 min

ecnp-stamp-podcast-blueFebruary 2022Catherine Harmer, United Kingdom, talks about her personal research path and the major findings on the mechanisms behind emotional processing and depression. She also discusses the novel findings on the cognitive mechanisms of the response to drugs used in the treatment of depression and anxiety.

Listen

Read more about Catherine Harmer and interviewer Aiste Lengvenyte.

*Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

Duration: 22 min

ecnp-stamp-podcast-blue

September 2021 — Declan Murphy, United Kingdom, is project coordinator of AIMS-2-TRIALS. The goal of the project is to better understand autism, to test new medicines, to better analyse data and to explore policies on autism. In this podcast, Prof Murphy shares his thoughts about the project and the future of autism research. 

Listen

*Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

Inaugural podcast — On career, research, and the renaissance of psychedelics*
Duration: 36 min

ecnp-stamp-podcast-blue

March 2021 — David Nutt, United Kingdom, a leading expert in neuropsychopharmacology, shares his thoughts about the major findings in brain science and the future of psychiatry. He also talks about his curious path as a psychiatrist-turned-researcher and a fierce advocate for evidence-based treatments and policies.

Listen

Read more about David Nutt and interviewer Aiste Lengvenyte.

*Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.